Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong

In a cohort of persons living with HIV in Hong Kong, surrogate virus neutralization testing for COVID-19 yielded a median level of 89% after the third dose of an inactivated COVID-19 vaccine, compared with 37% after the second dose. These results support using a 3-dose primary series for enhanced im...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Denise Pui Chung, Wong, Ngai Sze, Wong, Bonnie C.K., Chan, Jacky M.C., Lee, Shui Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514347/
https://www.ncbi.nlm.nih.gov/pubmed/36048772
http://dx.doi.org/10.3201/eid2810.220691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514347/
https://www.ncbi.nlm.nih.gov/pubmed/36048772
http://dx.doi.org/10.3201/eid2810.220691

Ejemplares similares